Redox Balance in Type 2 Diabetes: Therapeutic Potential and the Challenge of Antioxidant-Based Therapy

Area of Science:

• Biochemistry
• Endocrinology
• Metabolic Diseases

Background:

• Oxidative stress plays a key role in type 2 diabetes (T2D) development and complications.
• Current clinical evidence for antioxidant (AOX) benefits in T2D treatment is insufficient.
• Reactive oxygen species (ROS) have complex roles in glucose homeostasis, influencing both normal physiology and disease pathophysiology.

Purpose of the Study:

• To explore the role of oxidative stress in T2D pathophysiology.
• To review evidence on the failure of AOX therapy in diabetes management.
• To propose a hypothesis that suboptimal AOX dosing explains treatment failures.

Main Methods:

• Review of preclinical and clinical studies on AOX efficacy in T2D.
• Analysis of the impact of ROS on glucose homeostasis and insulin signaling.
• Examination of the relationship between oxidative stress markers and AOX dosing.

Main Results:

• Suboptimal dosing of AOXs in previous studies may account for the lack of observed benefits.
• Excessive AOX administration could potentially impair glycemic control by interfering with ROS signaling in insulin pathways.
• The effectiveness of AOX therapy is likely dependent on the individual's level of oxidative stress.

Conclusions:

• The failure of AOX therapy in T2D management may stem from inappropriate dosing strategies.
• Personalized AOX administration, tailored to individual oxidative stress levels, is recommended.
• Development of reliable biomarkers for oxidative stress is crucial for optimizing AOX therapy and maximizing its therapeutic potential.